{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2021-D-0691\" sorted by posted_date descending", "rows": [["FDA-2021-D-0691-0013", "FDA", "FDA-2021-D-0691", "Pharmacokinetic-Based Criteria for Supporting Alternative Dosing Regimens of Programmed Cell Death Receptor-1 or Programmed Cell Death-Ligand 1 Blocking Antibodies for Treatment of Patients With Cancer; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2022-12-06T05:00:00Z", 2022, 12, "2022-12-06T05:00:00Z", null, "2022-12-06T13:06:58Z", "2022-26464", 0, 0, "090000648551cdc8"], ["FDA-2021-D-0691-0014", "FDA", "FDA-2021-D-0691", "Pharmacokinetic-Based Criteria for Supporting Alternative Dosing Regimens of Programmed Cell Death Receptor-1 (PD-1) or Programmed Cell Death-Ligand 1 (PD-L1) Blocking Antibodies for Treatment of Patients with Cancer\nGuidance for Industry - Final Guidance", "Other", "Guidance", "2022-12-06T05:00:00Z", 2022, 12, "2022-12-06T05:00:00Z", null, "2024-11-07T00:44:34Z", null, 1, 0, "090000648550fc17"], ["FDA-2021-D-0691-0001", "FDA", "FDA-2021-D-0691", "Pharmacokinetic-Based Criteria for Supporting Alternative Dosing Regimens of Programmed Cell Death Receptor-1 or Programmed Cell Death\u0002Ligand 1 Blocking Antibodies for Treatment of Patients With Cancer; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2021-08-26T04:00:00Z", 2021, 8, "2021-08-26T04:00:00Z", "2021-10-26T03:59:59Z", "2021-10-26T01:00:33Z", "2021-18317", 0, 0, "0900006484ca8bc7"], ["FDA-2021-D-0691-0002", "FDA", "FDA-2021-D-0691", "Pharmacokinetic-Based Criteria for  Supporting Alternative Dosing  Regimens of Programmed Cell  Death Receptor-1 (PD-1) or  Programmed Cell Death-Ligand 1 \n(PD-L1) Blocking Antibodies for  Treatment of Patients with Cancer Guidance for Industry DRAFT GUIDANCE", "Other", "Guidance", "2021-08-26T04:00:00Z", 2021, 8, "2021-08-26T04:00:00Z", null, "2022-12-02T13:26:12Z", null, 0, 0, "0900006484ca880e"]], "truncated": false, "filtered_table_rows_count": 4, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2021-D-0691"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2021-D-0691", "results": [{"value": "FDA", "label": "FDA", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-D-0691&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2021-D-0691", "results": [{"value": "Notice", "label": "Notice", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-D-0691&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-D-0691&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2021-D-0691", "results": [{"value": 2021, "label": 2021, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-D-0691&posted_year=2021", "selected": false}, {"value": 2022, "label": 2022, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-D-0691&posted_year=2022", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-D-0691&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-D-0691&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-D-0691&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-D-0691&_facet=comment_start_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-D-0691&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-D-0691&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-D-0691&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-D-0691&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-D-0691&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 4050.6411369424313, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}